Lei Xu

Lei Xu

Auto-generated profile, based on publicly available information

Lei Xu

Guangdong Provincial Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation, Medical Research Center, Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University, Guangzhou 510120, P. R. China

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications

1 June 2014 in Human Gene Therapy Methods
Verified
Journal Article
Open access
CVCharles H. Vannoy
Charles H. Vannoy
LXLei Xu
Lei Xu
EKElizabeth Keramaris
Elizabeth Keramaris
PLPei Lu
Pei Lu
XXXiao Xiao
Xiao Xiao
QLQi L Lu
Qi L Lu
Multiple genes (e.g., POMT1, POMT2, POMGnT1, ISPD, GTDC2, B3GALNT2, FKTN, FKRP, and LARGE) are known to be involved in the glycosylation pathway of α-dystroglycan (α-DG). Mutations of these genes result in muscular dystrophies with wide phenotypic variability. Abnormal glycosylation of α-DG with decreased extracellular ligand binding activity is a common biochemical feature of these genetic diseases. While it is known that LARGE overexpression can compensate for defects in a few aforementioned genes, it is unclear whether it can also rescue defects in FKRP function. We examined adeno-associated virus (AAV)-mediated LARGE or FKRP overexpression in two dystrophic mouse models with loss-of-function mutations: (1) Largemyd (LARGE gene) and (2) FKRPP448L (FKRP gene). The results agree with previous findings that overexpression of LARGE can ameliorate the dystrophic phenotypes of Largemyd mice. In addition, LARGE overexpression in the FKRPP448L mice effectively generated functional glycosylation (hyperglycosylation) of α-DG and improved dystrophic pathologies in treated muscles. Conversely, FKRP transgene overexpression failed to rescue the defect in glycosylation and improve the phenotypes of the Largemyd mice. Our findings suggest that AAV-mediated LARGE gene therapy may still be a viable therapeutic strategy for dystroglycanopathies with FKRP deficiency.

15 January 2021 in Cell Death Discovery
Verified
Journal Article
Open access
PDF file
SYShigetoshi Yokoyama
Shigetoshi Yokoyama
SNShun Nakayama
Shun Nakayama
LXLei Xu
Lei Xu
APAprile L. Pilon
Aprile L. Pilon
SKShioko Kimura
Shioko Kimura
Non-canonical inflammasome activation that recognizes intracellular lipopolysaccharide (LPS) causes pyroptosis, the inflammatory death of innate immune cells. The role of pyroptosis in innate immune cells is to rapidly eliminate pathogen-infected cells and limit the replication niche in the host body. Whether this rapid cell elimination process of pyroptosis plays a role in elimination of cancer cells is largely unknown. Our earlier study demonstrated that a multi-functional secreted protein, secretoglobin (SCGB) 3A2, chaperones LPS to cytosol, and activates caspase-11 and the non-canonical inflammasome pathway, leading to pyroptosis. Here we show that SCGB3A2 exhibits marked anti-cancer activity against 5 out of 11 of human non-small cell lung cancer cell lines in mouse xenographs, while no effect was observed in 6 of 6 small cell lung cancer cell lines examined. All SCGB3A2-LPS-sensitive cells express syndecan 1 (SDC1), a SCGB3A2 cell surface receptor, and caspase-4 (CASP4), a critical component of the non-canonical inflammasome pathway. Two epithelial-derived colon cancer cell lines expressing SDC1 and CASP4 were also susceptible to SCGB3A2-LPS treatment. TCGA analysis revealed that lung adenocarcinoma patients with higherSCGB3A2mRNA levels exhibited better survival. These data suggest that SCGB3A2 uses the machinery of pyroptosis for the elimination of human cancer cells via the non-canonical inflammasome pathway, and that SCGB3A2 may serve as a novel therapeutic to treat cancer, perhaps in combination with immuno and/or targeted therapies.

25 November 2014 in Annals of the New York Academy of Sciences
Verified
Journal Article
Open access
PDF file
Ines LiebscherInes Liebscher
Ines Liebscher
Brian AckleyBrian Ackley
Brian Ackley
DADemet Araç
Demet Araç
DADonna M. Ariestanti
Donna M. Ariestanti
GAGabriela Aust
Gabriela Aust
XPXianhua Piao
Xianhua Piao
The class of adhesion G protein–coupled receptors (aGPCRs), with 33 human homologs, is the second largest family of GPCRs. In addition to a seven‐transmembrane α‐helix—a structural feature of all GPCRs—the class of aGPCRs is characterized by the presence of a large N‐terminal extracellular region. In addition, all aGPCRs but one (GPR123) contain a GPCR autoproteolysis–inducing (GAIN) domain that mediates autoproteolytic cleavage at the GPCR autoproteolysis site motif to generate N‐ and a C‐terminal fragments (NTF and CTF, respectively) during protein maturation. Subsequently, the NTF and CTF are associated noncovalently as a heterodimer at the plasma membrane. While the biological function of the GAIN domain–mediated autocleavage is not fully understood, mounting evidence suggests that the NTF and CTF possess distinct biological activities in addition to their function as a receptor unit. We discuss recent advances in understanding the biological functions, signaling mechanisms, and disease associations of the aGPCRs.

17 June 2024 in Nanoscale
Verified
Journal Article
Closed access
PDF file
YCYuan Cao
Yuan Cao
RXRui Xu
Rui Xu
YLYixia Liang
Yixia Liang
JTJiabao Tan
Jiabao Tan
XGXiaotang Guo
Xiaotang Guo
LXLei Xu
Lei Xu
Recently, nanotechnology has shown great potential in the field of cancer therapy due to its ability to improve the stability and solubility and reduce side effects of drugs. The biomimetic mineralization strategy based on natural proteins and metal ions provides an innovative approach for the synthesis of nanoparticles. This strategy utilizes the unique properties of natural proteins and the mineralization ability of metal ions to combine nanoparticles through biomimetic mineralization processes, achieving the effective treatment of tumors. The precise control of the mineralization process between proteins and metal ions makes it possible to obtain nanoparticles with the ideal size, shape, and surface characteristics, thereby enhancing their stability and targeting ability in vivo. Herein, initially, we analyze the role of protein molecules in biomineralization and comprehensively review the functions, properties, and applications of various common proteins and metal particles. Subsequently, we systematically review and summarize the application directions of nanoparticles synthesized based on protein biomineralization in tumor treatment. Specifically, we discuss their use as efficient drug delivery carriers and role in mediating monotherapy and synergistic therapy using multiple modes. Also, we specifically review the application of nanomedicine constructed through biomimetic mineralization strategies using natural proteins and metal ions in improving the efficiency of tumor immunotherapy.

10 July 2023 in Applied Physics Letters
Verified
Journal Article
Open access
PDF file
GLGuijiang Li
Guijiang Li
LXLei Xu
Lei Xu
ZDZhiwen Ding
Zhiwen Ding
ZCZhenhua Cao
Zhenhua Cao
In this study, the all-d-metal Heusler compounds Ni2MnT (T = Sc, Ti, V, Cr, Y, Zr, Nb, Mo, Hf, Ta, and W) were considered as representative examples, and the magnetism-dependent martensitic phase transition was systematically investigated by first-principles calculations. Comparative analysis of the calculated magnetic states-dependent elastic parameters, electronic structures, and thermodynamic parameters indicates that weakly magnetic Ni2MnT compounds with late transition metal atoms show higher possibilities of martensitic phase transition. Although magnetism is not the necessary condition for martensitic phase transition, the strong magnetic moment in Ni2MnT compounds with early transition metal atoms can suppress the occurrence of martensitic phase transition. When the magnetism is absent or becomes weak, the suppressed martensitic phase transition can be re-evoked. The current study indicates that magnetism plays an important role in determining the martensitic phase transition in all-d-metal Heusler compounds Ni2MnT. Careful control of the magnetism can serve as another parameter to tune martensitic phase transition in Ni−Mn-based all-d-metal Heusler compounds. This study can be helpful to explore and design outstanding candidate materials for solid-state refrigeration applications based on the martensitic phase transition.